These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17805301)

  • 1. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2.
    Dentin R; Liu Y; Koo SH; Hedrick S; Vargas T; Heredia J; Yates J; Montminy M
    Nature; 2007 Sep; 449(7160):366-9. PubMed ID: 17805301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.
    Liu Y; Dentin R; Chen D; Hedrick S; Ravnskjaer K; Schenk S; Milne J; Meyers DJ; Cole P; Yates J; Olefsky J; Guarente L; Montminy M
    Nature; 2008 Nov; 456(7219):269-73. PubMed ID: 18849969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism.
    Koo SH; Flechner L; Qi L; Zhang X; Screaton RA; Jeffries S; Hedrick S; Xu W; Boussouar F; Brindle P; Takemori H; Montminy M
    Nature; 2005 Oct; 437(7062):1109-11. PubMed ID: 16148943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling.
    Canettieri G; Koo SH; Berdeaux R; Heredia J; Hedrick S; Zhang X; Montminy M
    Cell Metab; 2005 Nov; 2(5):331-8. PubMed ID: 16271533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes.
    Muraoka M; Fukushima A; Viengchareun S; Lombès M; Kishi F; Miyauchi A; Kanematsu M; Doi J; Kajimura J; Nakai R; Uebi T; Okamoto M; Takemori H
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1430-9. PubMed ID: 19351809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes.
    Wang Y; Li G; Goode J; Paz JC; Ouyang K; Screaton R; Fischer WH; Chen J; Tabas I; Montminy M
    Nature; 2012 Apr; 485(7396):128-32. PubMed ID: 22495310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
    World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the CREB-specific coactivator TORC2 at Ser(307) regulates its intracellular localization in COS-7 cells and in the mouse liver.
    Uebi T; Tamura M; Horike N; Hashimoto YK; Takemori H
    Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E413-25. PubMed ID: 20551288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector.
    Screaton RA; Conkright MD; Katoh Y; Best JL; Canettieri G; Jeffries S; Guzman E; Niessen S; Yates JR; Takemori H; Okamoto M; Montminy M
    Cell; 2004 Oct; 119(1):61-74. PubMed ID: 15454081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2.
    Jansson D; Ng AC; Fu A; Depatie C; Al Azzabi M; Screaton RA
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10161-6. PubMed ID: 18626018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More TORC for the gluconeogenic engine.
    Cheng A; Saltiel AR
    Bioessays; 2006 Mar; 28(3):231-4. PubMed ID: 16479585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis.
    Wang Y; Vera L; Fischer WH; Montminy M
    Nature; 2009 Jul; 460(7254):534-7. PubMed ID: 19543265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.
    Shaw RJ; Lamia KA; Vasquez D; Koo SH; Bardeesy N; Depinho RA; Montminy M; Cantley LC
    Science; 2005 Dec; 310(5754):1642-6. PubMed ID: 16308421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2.
    Hogan MF; Ravnskjaer K; Matsumura S; Huising MO; Hull RL; Kahn SE; Montminy M
    J Biol Chem; 2015 Oct; 290(43):25997-6006. PubMed ID: 26342077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
    Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
    J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of gluconeogenic gene transcription by SIK1-induced ubiquitination and degradation of CRTC1.
    Gao WW; Tang HV; Cheng Y; Chan CP; Chan CP; Jin DY
    Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):211-223. PubMed ID: 29408765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.
    Caton PW; Nayuni NK; Kieswich J; Khan NQ; Yaqoob MM; Corder R
    J Endocrinol; 2010 Apr; 205(1):97-106. PubMed ID: 20093281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1.
    Ryu D; Oh KJ; Jo HY; Hedrick S; Kim YN; Hwang YJ; Park TS; Han JS; Choi CS; Montminy M; Koo SH
    Cell Metab; 2009 Mar; 9(3):240-51. PubMed ID: 19254569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes.
    Yano H; Sakai M; Matsukawa T; Yagi T; Naganuma T; Mitsushima M; Iida S; Inaba Y; Inoue H; Unoki-Kubota H; Kaburagi Y; Asahara SI; Kido Y; Minami S; Kasuga M; Matsumoto M
    Sci Rep; 2018 Sep; 8(1):14290. PubMed ID: 30250231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
    Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
    J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.